BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 17009244)

  • 1. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
    J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
    Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
    J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation.
    Tak PP; Gerlag DM; Aupperle KR; van de Geest DA; Overbeek M; Bennett BL; Boyle DL; Manning AM; Firestein GS
    Arthritis Rheum; 2001 Aug; 44(8):1897-907. PubMed ID: 11508443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
    Gillooly KM; Pattoli MA; Taylor TL; Chen L; Cheng L; Gregor KR; Whitney GS; Susulic V; Watterson SH; Kempson J; Pitts WJ; Booth-Lute H; Yang G; Davies P; Kukral DW; Strnad J; McIntyre KW; Darienzo CJ; Salter-Cid L; Yang Z; Wang-Iverson DB; Burke JR
    J Pharmacol Exp Ther; 2009 Nov; 331(2):349-60. PubMed ID: 19652024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
    Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
    Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
    Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
    Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extract of the dried heartwood of Caesalpinia sappan L. attenuates collagen-induced arthritis.
    Wang YZ; Sun SQ; Zhou YB
    J Ethnopharmacol; 2011 Jun; 136(1):271-8. PubMed ID: 21557995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
    Campagnuolo G; Bolon B; Feige U
    Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of daphnetin on adjuvant-induced arthritic rats.
    Gao Q; Shan J; Di L; Jiang L; Xu H
    J Ethnopharmacol; 2008 Nov; 120(2):259-63. PubMed ID: 18835428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor-related receptor-alpha (ERR-alpha) is dysregulated in inflammatory arthritis.
    Bonnelye E; Laurin N; Jurdic P; Hart DA; Aubin JE
    Rheumatology (Oxford); 2008 Dec; 47(12):1785-91. PubMed ID: 18927192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
    Badger AM; Blake S; Kapadia R; Sarkar S; Levin J; Swift BA; Hoffman SJ; Stroup GB; Miller WH; Gowen M; Lark MW
    Arthritis Rheum; 2001 Jan; 44(1):128-37. PubMed ID: 11212150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
    Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
    J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
    Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
    J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
    De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P
    J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat.
    Helyes Z; Szabó A; Németh J; Jakab B; Pintér E; Bánvölgyi A; Kereskai L; Kéri G; Szolcsányi J
    Arthritis Rheum; 2004 May; 50(5):1677-85. PubMed ID: 15146439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.